RE:RE:Time is running out...For sure, such therapies are still a few years away... but then approval from a phase III for mBC is 4 years away for ONCY.
And what would patiuents rather have, life extension of 10 months, or a cure. We still do not know whether addition of a CPI to the pela/pax doublet actually increases what was seen in IND-213.
Brad Thomson was on record stating that patients are living longer and longer, and this is why the H&N trial data was taking so long to mature... Then when it did..???
That was a Phase III trial, and it failed.
My point is, whilst we wait for more Phase II data, the field is moving... away from chemo + Pela + CPI, to Gene edited cures. What do you think the better investment is ?